M&A news

Affluent Medical Acquires Caranx Medical to

Caranx Medical acquired by Affluent Medical

AcquisitionProfessional ServicesFR

Get the full Caranx Medical company profile

Access contacts, investors, buying signals & more

Open in Dashboard
Caranx Medical logo
Acquired

Caranx Medical

FranceProfessional Services

Undisclosed amount

December 29, 2025

Affluent Medical logo
Acquirer

Affluent Medical

Affluent Medical has acquired Caranx Medical for an undisclosed amount, marking a strategic expansion into advanced surgical technology. This corporate acquisition sees Affluent Medical taking full ownership of Caranx Medical, integrating its innovative capabilities into the acquiring company's portfolio rather than providing a funding round.

Caranx Medical is recognized for its pioneering work at the intersection of imaging, artificial intelligence, and robotics. The company's core focus has been on developing sophisticated systems that aim to create an "auto-pilot for surgery," designed to enhance precision, safety, and efficiency in complex medical procedures through intelligent automation and real-time data processing. Its technology seeks to transform surgical interventions by providing unprecedented levels of control and assistance.

This acquisition is strategically significant for Affluent Medical, as it provides direct access to Caranx Medical's specialized expertise and intellectual property in AI-driven surgical robotics and advanced imaging. The integration is expected to accelerate Affluent Medical's ability to develop and deliver next-generation medical solutions, particularly in areas requiring high levels of automation and precision. Synergies are anticipated through the combination of Caranx's technological advancements with Affluent Medical's operational capabilities and market reach, fostering innovation in minimally invasive and automated surgical techniques. The move underscores a commitment to leveraging cutting-edge technology to address unmet needs in surgical care and improve patient outcomes.

The combined entity is now positioned to drive significant advancements in surgical automation, aiming to offer more standardized, precise, and potentially less invasive outcomes for patients. This integration is expected to strengthen Affluent Medical's competitive standing within the dynamic medical technology sector, particularly in the rapidly evolving fields of robotic-assisted surgery and intelligent medical imaging, shaping the future of surgical interventions.

No buying signals identified yet.

Unlock GTM signals

Discover Caranx Medical's tech stack and active buying intent.

View GTM signals

Unlock key decision-makers

Get direct access to the decision-makers at Caranx Medical.

Unlock decision-makers